Prediction of the risk for graft <i>versus</i> host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab-Reference-Cited by-同舟云学术

Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab

Published:2022-02-27 Issue:7 Volume:63 Page:1701-1707
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kamada Yuhei¹,Arima Naosuke¹,Hayashida Maiko¹,Nakamura Daisuke¹,Yoshimitsu Makoto¹,Ishitsuka Kenji¹

Affiliation:

1. Division of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2043300

Reference23 articles.

1. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

2. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1–Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis

3. High Level of Serum Soluble Interleukin-2 Receptor at Transplantation Predicts Poor Outcome of Allogeneic Stem Cell Transplantation for Adult T Cell Leukemia

4. A Retrospective Analysis of Treatment Outcomes in Adult T Cell Leukemia/Lymphoma Patients with Aggressive Disease Treated with or without Allogeneic Stem Cell Transplantation: A Single-Center Experience

5. Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL17, CCL22 and their receptor CCR4 in hematologic malignancies;Discover Oncology;2024-09-06

2. Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis;International Journal of Hematology;2024-03-27

3. A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post‐transplant clinical outcome in patients with aggressive ATL;British Journal of Haematology;2023-12-06

4. CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications;Biomedicines;2023-10-27

5. Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review;Biomolecules;2023-10-19